The bell-shaped concentration-effect curves for bispecific T-cell

Yanguang Cao's research works

Comparison of the free bispecific antibody (BsAb) concentration C

PDF) Physiological Considerations for Modeling in vivo Antibody

A Quantitative Systems Pharmacology Model of T Cell Engager

Immunotherapy combinations overcome resistance to bispecific T

Low-dose decitabine priming endows CAR T cells with enhanced and

Nanoparticle/Nanocarrier Formulation as an Antigen: The

Immunotherapy combinations overcome resistance to bispecific T

Development of bispecific T cell engagers: harnessing quantitative

Claudin18.2 bispecific T cell engager armed oncolytic virus

Age, dose, and binding to TfR on blood cells influence brain

PDF) Physiological Considerations for Modeling in vivo Antibody